FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 111 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Revumenib for Relapsed or Refractory Acute Myeloid Leukaemia with a Susceptible NPM1 Mutation Antitumour Activity of Patritumab Deruxtecan in Heavily Pretreated Patients with Active Brain Metastases of Breast Cancer and NSCLC EMA Recommends Extension of Indications for Sugemalimab MOST POPULAR Doctor Said Her Mammogram Results Were Normal, But Now She’s Fighting... August 25, 2020 Cancer and the Holidays December 3, 2021 pCR Correlates with RFS and OS with Neoadjuvant Therapy in Stage... February 16, 2021 Study Finds Accelerated Partial-Breast Radiation Just as Effective as Whole Breast... December 13, 2019 Load more HOT NEWS Three-Drug Regimen Improves Protection against GVHD after Stem Cell Transplant What to Know About Coping With Breast Cancer During Pregnancy: An... FDA Grants Accelerated Approval to Infigratinib for Metastatic Cholangiocarcinoma Daughter Surprises Terminally Ill Mom With Graduation Ceremony In Hospital Room.
